Our resource library is made available freely to all in order to advance responsible supply chain practices. Here you will find information and guidance on responsible supply chain issues and the way that the PSCI works. If you have any suggestions for improvements or additions to our resources please contact us.
The SAQ/Audit & Audit Guidance sub-team are pleased to publish the PSCI Pre-Audit Guidance Document Checklist. The checklist has been published as a separate document, previously found in the Audit Guidance as Annex 1.
The audit checklist summarizes important documents which the audit team may want to see in advance for audit preparation or want to review during the onsite audit visit. Depending on the type of supplier or the information provided as per SAQ, the list may be shortened (e.g. for service providers) or extended (e.g. for complex chemical or pharmaceutical manufacturers).
The checklist has been drafted using the current Full SAQ and Audit Report Template, suggesting documents that may be required for each principle (Governance & Management Systems, Ethics, Human Rights, Environment and Health & Safety) and corresponding question.
The Pharmaceutical Supply Chain Initiative (PSCI) and Accenture are pleased to announce the publication of the Decarbonization Playbook for the Pharmaceutical Industry (Playbook), an actionable playbook to guide pharmaceutical companies and their suppliers on the road to net zero.
Climate change poses the greatest health threat of the 21st century and the pharmaceutical industry is a key contributor to global emissions due to complex product lifecycles and an energy-intensive value chain.
Many pharmaceutical companies have set ambitious, science-based decarbonization goals but only 20% of life sciences companies are on track to achieve net zero by 2050. Advancing decarbonization can be slow as companies wrestle with various pain points across the product lifecycle but delays in decarbonizing expose companies to risks across the stakeholder landscape. Decarbonizing the pharmaceutical industry is a core component of the PSCI’s Environment Principle and PSCI members realize the importance of working together and with their suppliers across the whole value chain.
There have been several whitepapers published on the topic of health sector decarbonization. This Playbook builds on that work to provide 24 detailed emissions reduction initiatives across 7 impact areas that map to the drug development lifecycle. The initiatives were assessed in terms of addressability, emission reduction potential, implementation timeline, upfront cost, and regulatory complexity, and intervention adoption timeframe.
We welcome your feedback. If you have any input on the Playbook, please contact us for consideration in future updates.
EXCEL VERSION WITH IMPORT SHEET (FOR ONLINE SAQ ONLY)
PSCI Self Assessment Questionnaire and Audit Report Template for Service Providers & General Manufacturers with import sheet.
For optimum functionality, we recommend using the most up to date version Microsoft Excel. If you only have access to Excel 2003 or earlier, we recommend using the Word version of the SAQ.
To access the offline abbreviated SAQ template and full version history of the SAQ, follow this link.
Content version 8.0, simplified the Categorisation of Suppliers (Category A, B or C), removed/ added a few questions, rewording some questions, December 2021. Import sheet incorporated July 2023. Content version 9.0, full review and update of the SAQ. Section names and all questions revised to reflect the updated PSCI Principles, September 2024. Import sheet incorporated December 2024.
Full version template for Core Suppliers, External Manufacturers, Component and Material Suppliers are also available and come in multiple languages: Excel version full.
Please note: Content version 9.0 is only currently available in English with translations to follow soon.
The previous version of the SAQ is currently available in the following languages:
Español | Spanish
中文 (简体) | Chinese (simplified)
Português | Portuguese
日本語 | Japanese
The following links provide SAQ Online instruction documents for:
THE PSCI PRESENTS ITS SECOND PUBLIC AUDIT FINDINGS REPORT, PROVIDING CONTINUED INSIGHTS INTO SUPPLIER RISKS, TRENDS, AND AREAS FOR IMPROVEMENT ACROSS THE PHARMACEUTICAL AND HEALTHCARE SUPPLY CHAIN.
This report shares our analysis of findings from PSCI audits available on our platform. Each year, we review these in line with the PSCI Principles to identify trends, highlight improvements, and share recommendations. Overall, this analysis provides deep insight into supplier practices within the pharmaceutical and healthcare industry and guides us on developing targeted resources and trainings.
The year’s report analyzes 1,776 findings from 180 supplier audits uploaded to the PSCI platform in 2023. These findings are categorized into 308 Management Systems findings, 7 Ethics findings, 169 Human Rights findings, 970 Health & Safety findings, and 322 Environment findings, offering a comprehensive overview of supplier practices and opportunities for improvement. The report includes a summary of findings across key topics, detailed breakdowns with recommended actions for suppliers, and links to relevant
What’s new this year?
The first-ever analysis by supplier type, providing tailored insights into specific supplier categories.
A regional analysis focused on major pharmaceutical manufacturing hubs, including China and India.
A deep-dive analysis of 13 suppliers’ audit data over three years, exploring changes in supplier practices and measuring PSCI’s impact.
The report reinforces the PSCI’s role as a catalyst for continuous improvement, equipping suppliers with tools and guidance to enhance practices and adapt to evolving demands. For more details, access the full report in the resource attached.
You're Invited: PSCI Global Supplier Conference 2025!
Get ready for a highly regarded line-up of expert speakers, insightful discussions, and actionable strategies to drive sustainability in pharmaceutical supply chains.
🔎 Featured Sessions:
Legislation & Trends – Stay ahead of key legislation on Wastewater, Due Diligence, and Human Rights, and explore current pressures on the pharmaceutical industry related to antimicrobial resistance
Hands-On Solutions – Explore practical strategies on cybersecurity in process safety, data integration in risk assessments, safety excellence, and more!
PSCI Showcase – Gain insights into the Pharma LCA and PSCI’s Decarbonization Partnerships
📅 Download the full agenda below. To register, click here.
Don’t miss this opportunity to connect, learn, and contribute to the future of sustainable value chains. Secure your spot today and make every session count!
📩 Spread the Word: Forward this invitation to your colleagues.
If you have any questions, feel free to reach out at info@pscinitiative.org.
The first session of the 2024 PSCI China Supplier Conference took place on September 10, covering Management, Human rights & labor, and Decarbonization.
2024年中国供应商大会第一天于成都线下举行，覆盖管理体系、劳工、减碳议题。
Speaker:
Jennifer Jiang | Partner | ERM
演讲嘉宾：
姜煜瑶 | 合伙人 | 伊尔姆
Topic: Scope 3 and Decarbonization
议题：范围三和脱碳
To access the slides, please click "DOWNLOAD". 下载会议PPT，请点击下方DOWNLOAD按钮
The first session of the 2024 PSCI China Supplier Conference took place on September 10, covering Management, Human rights & labor, and Decarbonization.
2024年中国供应商大会第一天于成都线下举行，覆盖管理体系、劳工、减碳议题。
The first session of the 2024 PSCI China Supplier Conference took place on September 10, covering Management, Human rights & labor, and Decarbonization.
2024年中国供应商大会第一天于成都线下举行，覆盖管理体系、劳工、减碳议题。
Speaker:
Lin Wang, Director, BSR China
演讲嘉宾：
王林，中国区总监，商业社会责任
Topic: China labor market practice and impact to business
议题：中国劳动市场的实践以及对商业的影响
To access the slides, please click "DOWNLOAD". 下载会议PPT，请点击下方DOWNLOAD按钮
The first session of the 2024 PSCI China Supplier Conference took place on September 10, covering Management, Human rights & labor, and Decarbonization.
2024年中国供应商大会第一天于成都线下举行，覆盖管理体系、劳工、减碳议题。
Speaker:
Jason Jiang| EHS Lead| GSK
Eric Peng| Regional Category Manager| Astra Zeneca
演讲嘉宾：
姜兴| EHS负责人 | 葛兰素史克
彭诗达| 亚太区采购经理 | 阿斯利康
Topic: Human Rights Audits Common Findings & CAPs
议题：劳动者权益审计常见发现项&整改方案| 劳动者权益话题分享
To access the slides, please click "DOWNLOAD". 下载会议PPT，请点击下方DOWNLOAD按钮
The first session of the 2024 PSCI China Supplier Conference took place on September 10, covering Management, Human rights & labor, and Decarbonization.
2024年中国供应商大会第一天于成都线下举行，覆盖管理体系、劳工、减碳议题。
Speaker:
Jing DONG | Managing Director | Peterson Solutions China
演讲嘉宾：
董菁 | 总经理 | 上海佩笙检测有限公司
Topic: Social Sustainability in Upstream Supply Chain via Responsible Sourcing Process
议题：通过负责任采购实现上游供应链中的社会可持续发展
To access the slides, please click "DOWNLOAD". 下载会议PPT，请点击下方DOWNLOAD按钮
The first session of the 2024 PSCI China Supplier Conference took place on September 10, covering Management, Human rights & labor, and Decarbonization.
2024年中国供应商大会第一天于成都线下举行，覆盖管理体系、劳工、减碳议题。
Speaker:
Gary Lu | APAC SHE & Sustainability Director | AstraZeneca
演讲嘉宾：
卢罡 | 亚太区安全健康环保及可持续发展总监 | 阿斯利康
Topic: China Green Power Project
议题：中国绿电项目
To access the slides, please click "DOWNLOAD". 下载会议PPT，请点击下方DOWNLOAD按钮
The first session of the 2024 PSCI China Supplier Conference took place on September 10, covering Management, Human rights & labor, and Decarbonization.
2024年中国供应商大会第一天于成都线下举行，覆盖管理体系、劳工、减碳议题。
Speaker:
Joyce Jiang| Sr Sustainability & Compliance manager, Global Procurement| Roche (Shanghai) Pharmaceuticals Consulting Co.,Ltd.
演讲嘉宾：
蒋南婧 | 全球采购-可持续发展与合规高级经理 | 罗氏（上海）医药咨询有限公司
Topic: Roche’s Journey to Decarbonise its Supply Chain - Challenges & Mitigation
议题：罗氏供应链的减碳之旅-挑战和行动
To access the slides, please click "DOWNLOAD". 下载会议PPT，请点击下方DOWNLOAD按钮
The second session of the 2024 PSCI China Supplier Conference took place on September 11, covering Environment, Industrial Hygiene, General Safety, and Process Safety.
2024年中国供应商大会第二天于南京线下举行，覆盖环境、工业卫生、安全总览、过程安全议题。
Speaker:
Don Yu| BD Manager| BSI
演讲嘉宾：
于东 | 商务经理 | 英国标准协会
Topic: BSI Kitemark™ for minimized risk of antimicrobial resistance
议题：BSI与抗生素耐药性认证
To access the slides, please click "DOWNLOAD". 下载会议PPT，请点击下方DOWNLOAD按钮
The second session of the 2024 PSCI China Supplier Conference took place on September 11, covering Environment, Industrial Hygiene, General Safety, and Process Safety.
2024年中国供应商大会第二天于南京线下举行，覆盖环境、工业卫生、安全总览、过程安全议题。
The second session of the 2024 PSCI China Supplier Conference took place on September 11, covering Environment, Industrial Hygiene, General Safety, and Process Safety.
2024年中国供应商大会第二天于南京线下举行，覆盖环境、工业卫生、安全总览、过程安全议题。
Speaker:
William Zhu | Associate Director | WSP
演讲嘉宾：
朱人 | 副技术总监 | 科进
Topic: Statistical Analysis of Industrial Hygiene Monitoring Data
议题：工业卫生数据的统计分析
To access the slides, please click "DOWNLOAD". 下载会议PPT，请点击下方DOWNLOAD按钮
The second session of the 2024 PSCI China Supplier Conference took place on September 11, covering Environment, Industrial Hygiene, General Safety, and Process Safety.
2024年中国供应商大会第二天于南京线下举行，覆盖环境、工业卫生、安全总览、过程安全议题。
The first session of the 2024 PSCI China Supplier Conference took place on September 11, covering Environment, Industrial Hygiene, General Safety, and Process Safety.
2024年中国供应商大会第二天于南京线下举行，覆盖环境、工业卫生、安全总览、过程安全议题。
Speaker:
Carl Deng | Senior Process Safety Consultant | DEKRA Shanghai Office
The 2024 PSCI India Supplier Conference in Goa brought together over 700 participants for three days of insightful discussions and networking. Featuring keynote speeches from industry leaders, expert panels, PSCI’s first-ever exhibition, and an auditors' panel, the conference showcased the PSCI’s commitment to advancing responsible supply chain practices.
This slide deck, presented by N T Prasad, Head EHSS Bangalore, Syngene International Limited during the "Process Safety" session at the PSCI India Supplier Conference 2024 in Goa, India.
This resource covers key trends, challenges, and best practices relevant to PSCI members and suppliers, the resource is designed to enhance understanding, with actionable strategies and case studies relevant to India and the broader region. Perfect for those looking to deepen their knowledge in sustainable supply chain management and industry collaboration.
The Pharmaceutical Supply Chain Initiative (PSCI) has released its 2023 Annual Report, celebrating its 10th anniversary and showcasing the efforts of the pharmaceutical and healthcare industry to build responsible supply chains. The report showcases the sector’s progress through its three modes of impact: Audit, Capability, and Projects.
More Info…
Audit
Reducing the burden on suppliers through an industry-supported audit framework and sharing platform
983 audits available on the PSCI shared audit platform
7000+ downloads of audits by the PSCI membership
Capability
Supporting continual supplier improvement through engaging, educational content
1800+ attendees on our webinar program, our largest audience ever
900 attendees joined two Supplier Conferences delivered in-person in China & India and first-ever Global Conference for suppliers in Europe and North America
Launch of a new, on-demand e-learning platform for suppliers, Learnster
Projects
Leveraging reach and scale to create positive impact
Launch of a progressive position paper on Horseshoe Crab blood usage for the sector
Development of a new Supplier Partnership category to recognize suppliers that can evidence their commitment to responsible practices
Ingrid Vande Velde, 2023 PSCI Chair says,
When our founding members joined together in 2013, they had a vision of crystallizing their collective knowledge to create a transparent, efficient, and sustainable supply chain. Reflecting on the past decade, it’s clear that we’ve made tremendous advances towards that original vision, and understand what remains to be achieved on the road ahead.
Deirdre O’Reilly, 2024 PSCI Chair says,
Reflecting on the achievements of 2023, it’s impressive and humbling to see the sheer energy and dedication of the members that drive the PSCI, especially those in leadership roles for our various Committees and Teams. Their commitment fuels the PSCI’s success and our energy for the future.
Address for correspondence is: LinkRFP@pscinitiative.org
Please confirm your interest to participate by: 10th May 2024
Bid submission deadline: 31st May 2024
PSCI has conducted a materiality review for the sector every few years (2013, 2017, 2020). We are pleased to publish our latest assessment, this time applying a double materiality framework. The assessment is specifically focused on supply chains for the Pharmaceutical & Healthcare industries, and takes into account member views and a range of outside sources. (For more detail about the double materiality approach, please see here.)
The initial materiality was conducted in Summer 2023 to support development of the new strategy. This has since been updated to take into take into account the final CSRD and to add an additional checking stage to the scoring and issues list.
We encourage members, suppliers and our other stakeholders and invited to read the report and use it as an input to their own planning processes.
For anyone with comments to the report, please contact Rosie.Towe@Carnstone.com.
The PSCI shares its first public Audit Findings Report, providing insight and visibility over key risks, trends, and improvements in the pharmaceutical and healthcare supply chain.
As part of the PSCI's goal to promote consistency, quality, and innovation in all aspects of supplier evaluation and audit, we analyze PSCI audits conducted and uploaded on our shared platform on an annual basis. This report shows what we’ve found by analyzing 3,500 findings from 339 PSCI audits conducted during 2020-2022 and uploaded to the PSCI platform by the end of 2022.
We are specifically interested in understanding how the findings are distributed across the five areas of the PSCI Principles, our blueprint for responsible supply chain management & foundation of our tools. This analysis gives us visibility over how findings are changing over time and our impact on the industry.
This report, the first we have shared publicly, shows the results of a deep dive analysis into each area, focusing on 1,955 findings from 195 PSCI audits uploaded by the end of 2022. These findings reveal key risks, areas for improvement, and opportunities for PSCI members to support their suppliers to improve their practices.
This analysis also provides a high-level understanding of regional differences and levels of maturity, allowing us to provide regionally specific support on hot topics through our capability building work and begin to understand our own impact on the industry.
Speaking of the report's publication, Dorota Wiacek-Trojanowska, Audit Committee member says,
The annual analysis of audit results carried out by the PSCI not only provides information enabling the identification of the most important challenges faced by both PSCI members and suppliers, but also shows new challenges that we must be able to face. The audit results give us the opportunity to collect and analyze information on the biggest challenges in ensuring a sustainable supply chain in the whole pharma sector.
The PSCI has published our 2022 Annual Report, summarizing a year of growing connections and clear movement towards achieving our shared vision of excellence in safety, environmental, and social outcomes across the global pharmaceutical and healthcare supply chain.
Key developments in 2022 include
Growth to 74 members (an increase of 40% on 2021), with 18 new Associate members
Developed the PSCI Maturity Models to support structured supplier learning, and in early 2023 launched an app called PSCI Maturity (available in both the Android and iOS stores)
32% increase in audits available on the PSCI platform; 801 total & 196 new audits uploaded in 2022
Over 2,100 supplier attendees at our capability building conferences in India and China
Became the Official Sustainability Partner of CPHI Worldwide
Vicki Stone-Bjarup, 2022 Chair of the PSCI, says,
Sectors around the world are working to tackle the sustainability challenges of their industry. This report transparently shares the successes that PSCI members have achieved for our sector over the last year, as well as the journey left to take. There is still a long way to go, but we are so proud to be a part of the progress being made in the pharmaceutical industry. Our focus remains to support our members to build responsible supply chains.
Decarbonizing the pharmaceutical industry in line with global efforts is a core component of PSCI’s environmental principle. Action is needed and PSCI members realize the importance of working together with their suppliers, often the majority of the footprint across the whole value chain.
This is why we're pleased to launch the PSCI Decarbonization Pathway, a tool that the industry can use to move towards a net zero value chain, in line with global goals such as the COP Paris Agreement and UN Sustainable Development Goals. The maturity model provides a clear pathway for suppliers to develop their capability and response towards reducing their carbon emissions.
PSCI Members, through their Decarbonization team and partnerships with leading organisations, will continue to provide the resources that suppliers will need in this journey.
In this video, the PSCI reiterates its commitment to supporting our members to understand human rights practices in pharmaceutical supply chains and outlines the resources available to help make it happen across the industry.
Together with our members, the PSCI understands that society and business are best served by responsible business behaviors and practices. With our training materials, conferences, and tools, we aim not only to ensure the upholding of our Principles, but also to support all our members in implementing the United Nations’ Guiding Principles on Business and Human Rights in their supply chain and improving their human rights impacts around the world.
The first session of the 2022 PSCI China supplier conferences took place virtually on 6 September and covered Ethics, Labor, Management systems.
2022年中国供应商线上会议第一场于9月6日在线上举行，覆盖伦理，劳工，管理议题。
Speaker: Roderick | Technical director | Shanghai STRM Technology Co., Ltd.
演讲嘉宾：员文权 | 技术总监 | 上海翊员科技有限公司 Topic: Business continuity plan
议题：业务连续性计划
The third session of the 2022 PSCI India supplier conferences took place in-person on the 23rd of September and covered Human Rights & Labor and Ethics.
The full slide deck is available for download below.
The presentations covered are as follows:
PSCI Human Rights & Labor Maturity Model Dinesh Subhedar, Head of Third Party Labor Rights - India & West Asia, Novartis Alexandrea Kunde, Partner, PSCI Secretariat – Carnstone Partners Ltd.
Responsible Procurement Ashish Mohan | Vice President – Procurement, BSV Group
Psychological Safety Rishu Roy, Chairperson, ISTD (Indian Society of Training and Development) Indore Chapter | Professor, Shri Vaishnav Vidyapeeth Vishwavidhayalaya
Management of Change – Application of Digital Tools Anjali Sandesh, Associate Director, Benchmark ESG Naveen GV, Corporate Officer & Manager Director, Benchmark ESG
Data Privacy – General Introduction and Legislations Neeru Walia, Associate Director, Deloitte Sowmya Vedarth, Partner, Deloitte
The second session of the 2022 PSCI India supplier conferences took place in-person on the 22nd of September and covered Audit, Environment, Scope 3, PiE/AMR
The full slide deck is available for download below.
Engaging Suppliers to Reduce Scope 3 Emissions Towards Net Zero Robert Williams, Director of Procurement Sustainability, Astra Zeneca
Ban on Identified Single Use Plastic – The Whats, Whys and Hows Ashish Jain, Founder-Director, Indian Pollution Control Association (IPCA)
Climate change – Risks to Organizations Shivananda Shetty, Partner & Head, ESG and Climate Change, KPMG
Supplier Water Quality & Pharmaceuticals in Environment Balaji Gurumurthy, Environmental Compliance Lead, Novartis
Reducing AMR Risk Through Effective Control of Antibiotic Manufacturing Emissions Dharmesh Kharwar, Director, NGB Laboratories
PSCI Musi River Project Manjit Singh, Associate Director of Corporate Sustainability, Centrient Pharmaceuticals Senthil Kumar, Supplier Operations, Pfizer
Case studies – Implementation of Good Practice in Management of API Containing Waste Streams Ashok Kumar Podisetty, Head of EHS, Neuland Laboratories Limited
Developing PiE/AMR Capabilities in India Aditya Shirodkar, Global Senior EHS Specialist, Abbott
The first session of the 2022 PSCI India supplier conferences took place in-person on the 21st of September and covered Safety and Process Safety Management.
The full slide deck is available for download below at "View More".
The presentations covered are as follows:
PSCI Safety Principle - Supplier Maturity Model Vijaya Sarathy, EHS Manager, West Pharmaceuticals Services
Business Continuity Plans Ranjana Ganguly, EHS Vice President - India, Pfizer Amish Kamat, EHS Regional Manager - APAC, Bayer Dr JVN Reddy, President, Aurobindo Vijaya Sarathy, EHS Manager, West Pharmaceuticals Services Declan Kielty, Business Resilience Leader, Pfizer
Process Safety Management: General Introduction Vijaya Kumar Bendi, Manager-ESE, HS&S, Johnson & Johnson
Hazardous Area Classification M. Sasikumar, General Manager, Cholamandalam MS Risk Services
Approach for Implementing Risk Based Process Safety Management Systems as per Centre for Chemical Process Safety Sivala Ravi Kiran, Head of Corporate EHS & Sustainability, Biocon
The PSCI is pleased to introduce the Maturity Models in this informative video. The Maturity Models are a very useful tool for suppliers to evaluate their current practices and plot a course for improvement. They allow users to evaluate their company practices against the PSCI Principles and signpost the user to the resources needed to progress.
The PSCI is pleased to introduce the Maturity Models in this informative video. The Maturity Models are a very useful tool for suppliers to evaluate their current practices and plot a course for improvement. They allow users to evaluate their company practices against the PSCI Principles and signpost the user to the resources needed to progress.
Surrogates such as naproxen sodium, lactose and mannitol are used in place of an API to determine particulate containment provided by a containment equipment such as an isolator. Selection of a surrogate, surrogate properties (moisture content, particle size distribution), methods for surrogate monitoring, locations of area positional samples, and Containment Performance Target (CPT) concentrations, are critical in the decision making, among other factors. The speakers will share surrogate monitoring methods utilizing ISPE Good Practice Guide: Assessing the Particulate Containment Performance of Pharmaceutical Equipment.
The webinar was created by:
• Maharshi Mehta, CIH, CSP, FAIHA, President
• Ankit Sharma, CIH, LFOH, Associate Director, International Safety Systems, Inc (ISS)
Today the PSCI published its 2021 Annual Report, summarizing a year of exceptional advancement towards achieving our shared vision of excellence in safety, environmental, and social outcomes across the global pharmaceutical and healthcare supply chain.
Key developments in 2021 include:
Growth in membership, with 53 member companies adopting the PSCI Principles
Increased audit sharing, with 116 new audits uploaded to our bespoke audit sharing platform
Finalization of our master supplier learning curriculum, with the launch of our eight maturity models for suppliers to use to advance their practices
Unprecedented levels of supplier engagement through two large-scale Virtual Supplier Conferences in China and India, reaching 2,000+ attendees
Promising insights on our impact on the industry, with preliminary analysis on audit data showing that our influence supports positive change on supplier practices
Manjit Singh, 2021 PSCI Chair and Associate Director of Corporate Sustainability at Centrient Pharmaceuticals says,
2021 was a year of spectacular growth for the PSCI in membership and activity. Despite the second year of the Covid-19 pandemic, every aspect of the PSCI's program developed and grew from our shared audits to our supplier capability interactions. I have appreciated the professional and energetic contribution of my fellow PSCI members and watched with great pride the growth of the organization and the impact it has upon our entire industry.
You can read about these advancements and more in the report below.
We welcome comments and encourage you to share this report with your networks using the hashtag #PSCIAnnualReport.
The PSCI is pleased to continue supporting the work of the Telangana State Government in India to revitalize the Musi River.
The Musi River flows through Hyderabad in Telangana State, Southern India. It is fed by the world-heritage Hussein Sagar lake, also called the “heart of the world”, and used to be enjoyed by locals and tourists alike for its beauty and amenity. Yet, there have been numerous reports of polluted effluents and poor wastewater management practices affecting the lake and the Musi River watershed, impacting local communities over many years.
For World Water Day 2021 (22 March), we published a statement outlining our support for the State government's initiative and our plans to help. We aimed to use our influence to engage with suppliers of PSCI members in Telangana to promote better wastewater practices and encourage positive change. Our aim is that every single supplier with a connection to a PSCI member should be visited, audited or contacted directly to promote the best technologies for wastewater management.
One year later, we're pleased to share an update on progress made. Since March 2021, we have
Held dedicated sessions on wastewater treatment technology at our Virtual Supplier Conference in India
Created a baseline of all pharmaceutical companies in the Musi River catchment area to identify connections with PSCI member companies
Our aim is that all suppliers to PSCI members should provide information about their wastewater treatment practices, either via member visit, questionnaire, or a full site audit shared on our platform.
To continue this work, we will
encourage suppliers to share audits and work with our members to encourage site visits or audits
offer audits free of charge to suppliers in the Musi River catchment area
promote our PEC:PNEC calculator for assessing API discharges
We hope to contribute to restoring the Musi River to its former health.
The Audit Committee has recently conducted a light refresh on the SAQ/Audit Excel template, and the Audit Guidance document. The new versions are now available on the Link.
This webinar covered the following topics:
Updates to the SAQ/Audit templates
Updates to the Audit Guidance documents
Latest news from Audit Committee, including plan to move the SAQ online
At the PSCI, we’re committed to supporting all our members to implement the United Nations’ Guiding Principles on Business and Human Rights (UNGPs) as part of our mission to drive excellence in safety, environmental, and social outcomes across the pharmaceutical and healthcare supply chain.
That’s why for Human Rights Day (10 December), we’re excited to launch our new Position Statement, which provides an overview of the role we play in helping our members and suppliers align their practices with the UNGPs through the PSCI Principles for Responsible Supply Chain Management and our resources.
With our training materials, webinars, and tools we aim not only to ensure the upholding of our Principles, but also to support all our members in implementing the UNGPs across their entire supply chains.
EXCEL VERSION
PSCI Self Assessment Questionnaire and Audit Report Template for Core Suppliers, External Manufacturers, Component and Material Suppliers
For optimum functionality, we recommend using the most up to date version Microsoft Excel. If you only have access to Excel 2003 or earlier, we recommend using the Word version of the SAQ.
Content Version 6, February 2019
Content Version 7, remote audit options added, October 2020
Content version 7.1, small technical fixes, including correctly referencing finding type on CAP tab, showing suppliers responses to topic areas that are not audited, May 2021
Content version 7.2, fix formating issue of finding classifications on the Company Specific Questions tab, June 2021
Content version 8.0, simplified the Categorisation of Suppliers (Category A, B or C), removed/ added a few questions, rewording some questions, December 2021 Content version 9.0, full review and update of the SAQ. Section names and all questions revised to reflect the updated PSCI Principles, September 2024.
Abbreviated version template for Service Providers & General Manufacturers are also available: Excel version.
Please note: Content version 9.0 is only currently available in English with translations to follow soon.
The previous version of the SAQ is currently available in the following languages:
